EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Dr Reddy's Laboratories's enterprise value is R$59,295 Mil.
Dr Reddy's Laboratories's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was R$16,301 Mil. Therefore, Dr Reddy's Laboratories's EV-to-Revenue for today is 3.64.
The historical rank and industry rank for Dr Reddy's Laboratories's EV-to-Revenue or its related term are showing as below:
BSP:R1DY34'
s EV-to-Revenue Range Over the Past 10 Years
Min: 2.48 Med: 3.38 Max: 4.93
Current: 3.52
During the past 13 years, the highest EV-to-Revenue of Dr Reddy's Laboratories was 4.93. The lowest was 2.48. And the median was 3.38.
BSP:R1DY34's EV-to-Revenue is ranked worse than 67.41% of 1025
companies
in the Drug Manufacturers industry
Industry Median: 2.33
vs BSP:R1DY34: 3.52
As of today (2024-04-19), Dr Reddy's Laboratories's stock price is R$62.64.
Dr Reddy's Laboratories's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was R$16.31. Therefore, Dr Reddy's Laboratories's PS Ratio for today is 3.84.
Dr Reddy's Laboratories EV-to-Revenue Historical Data
The historical data trend for Dr Reddy's Laboratories's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Dr Reddy's Laboratories Annual Data
Trend
Mar14
Mar15
Mar16
Mar17
Mar18
Mar19
Mar20
Mar21
Mar22
Mar23
EV-to-Revenue
3.08
2.94
3.92
3.28
2.93
Dr Reddy's Laboratories Quarterly Data
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
EV-to-Revenue
2.83
2.93
3.10
3.28
3.36
Competitive Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Dr Reddy's Laboratories's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr Reddy's Laboratories EV-to-Revenue Distribution
For the Drug Manufacturers industry and Healthcare sector, Dr Reddy's Laboratories's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Dr Reddy's Laboratories's EV-to-Revenue falls into.
Dr Reddy's Laboratories's current Enterprise Value is R$59,295 Mil.
Dr Reddy's Laboratories's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was R$16,301 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr Reddy's Laboratories (BSP:R1DY34) EV-to-Revenue Explanation
Dr Reddy's Laboratories's share price for today is R$62.64.
Dr Reddy's Laboratories's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was R$16.31.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr Reddy's Laboratories EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Dr Reddy's Laboratories's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Dr Reddy's Laboratories (BSP:R1DY34) Business Description
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (22% of its generics sales), Russia (12%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BSP:R1DY34 has been successfully added to your 